Oncology
The sponsor’s oncology portfolio includes clinical research in metastatic pancreatic ductal adenocarcinoma, with attention to patients whose disease has remained controlled after first-line multiagent chemotherapy. This area reflects interest in maintenance strategies for advanced gastrointestinal malignancy and treatment-sensitive metastatic disease.
- Pancreatic cancer
- Metastatic PDAC
- Maintenance therapy
Research activity in this field is centered on targeted therapy for chemotherapy-sensitive disease and the clinical management of advanced solid tumours.
Psychiatry
Another area of interest is depressive disorders in adults whose symptoms are currently in remission, with trials examining strategies for stopping long-term antidepressant treatment. The focus is on relapse prevention and the clinical course after medication discontinuation.
- Remitted depression
- Antidepressant discontinuation
- Relapse monitoring
This psychiatric research domain addresses treatment decisions in mood disorders and medication tapering in stable patients.
Supportive Clinical Care
The sponsor’s studies also involve clinical questions relevant to long-term treatment management, including how patients transition off ongoing pharmacological therapy and how symptom recurrence is tracked over time. These topics connect routine care with structured follow-up in both mental health and oncology settings.
- Treatment discontinuation
- Clinical follow-up
- Patient stability
Within this area, the sponsor’s research interest extends to maintaining disease control while reducing reliance on chronic medication.
